MedTrace Logo

Assessing the Generalizability of the Tachidino Protocol to Different Clinical Contexts

NCT04384718 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2020-05-12

No results posted yet for this study

Summary

The study aims to document the effectiveness and acceptability of the intervention system for specific reading and writing disorders, in use at Scientific Institute (IRCCS) Medea, as applied and adapted to a different clinical context and socio-demographic situation. To this purpose, two groups of children will be recruited and treated in two different contexts, and treatment outcomes will be compared. The first one is the centre where the Tachidino platform has been developed and validated, the second one is a different centre, in a different geographical region where lower digital alphabetization may be a disadvantaging factor, but lower population density and the presence of fewer centres for assessment and intervention for learning disorders make remotely monitored protocols even more valuable.

Conditions

  • Developmental Dyslexia

Sponsors & Collaborators

  • University of Urbino "Carlo Bo"

    collaborator OTHER

  • Asur Marche - AV1 - Centre for Clinical Child Neuropsychology

    collaborator UNKNOWN

  • IRCCS Eugenio Medea

    lead OTHER

Principal Investigators

  • Maria L Lorusso, Ph.D. · IRCCS E. Medea

Eligibility

Min Age
7 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2021-09-30
Completion
2021-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04384718 on ClinicalTrials.gov